Cialis (tadalafil)
- Region
- 🇪🇺 EU
- Active substance
- tadalafil
- Company
- Eli Lilly Nederland B.V.
- Status
- Authorised
- Therapeutic area
- Erectile Dysfunction
- CHMP opinion
- Thu 25 Jul 2002
- EU approval
- Tue 12 Nov 2002
- Application
- EMEA/H/C/000436
- ATC
- G04BE08
- Official record
- www.ema.europa.eu
Indication
Treatment of erectile dysfunction. In order for tadalafil to be effective, sexual stimulation is required. Cialis is not indicated for use by women.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Tadalafil Mylan Authorised · Mylan Pharmaceuticals Limited
- 🇪🇺 Yuvanci Authorised · Janssen-Cilag International NV
- 🇪🇺 Talmanco (previously Tadalafil Generics) Authorised · Viatris Limited
- 🇪🇺 Adcirca (previously Tadalafil Lilly) Authorised · Eli Lilly Nederland B.V.
- 🇪🇺 Tadalafil Lilly Authorised · Eli Lilly Nederland B.V.
Follow Cialis
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.